Cited 3 times in
Prediction of Sustained Virologic Response Based on Week 4 and Week 12 Response in Hepatitis C Virus Genotype 1 Patients Treated with Peginterferon and Ribavirin: Assessment in a Favorable IL28B Allele-Prevalent Area
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.